慢性疼痛の世界市場レポート 2025年

慢性疼痛の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.5％で1,177億4,000万米ドルに成長します。予測期間の成長は、高齢化、遠隔医療の拡大、公衆衛生意識、遺伝子研究と精密医療、心理社会的ストレス要因に起因すると考えられます。予測期間の主な動向には、ウェアラブルデバイスの統合、疼痛教育と支援グループ、ホリスティック疼痛管理、非オピオイド疼痛管理、疼痛の再生医療などが含まれます。

慢性疼痛患者の増加は、慢性疼痛市場の成長を促進すると予測されます。慢性疼痛患者とは、一般的な治癒プロセスを超えて継続的または長期的に続く痛みを経験する患者であり、一般的に3ヵ月以上続きます。慢性疼痛患者の多さが市場の成長を促進し、医薬品や医療機器を含む効果的な疼痛管理ソリューションに対する需要の高まりが、業界内の技術革新と市場開拓の機会を生み出しています。例えば、2024年6月、オーストラリアの政府機関であるAustralian Institute of Health and Welfareは、2022年に推定400万人のオーストラリア人（人口の16%）が背中の問題を抱えながら生活していると報告しました。2023年までに、背中の問題は疾病負担の第3位となり、国の疾病負担全体の4.3％を占めるようになりました。さらに、2024年2月、米国を拠点とする公衆衛生機関であり研究機関であるInstitute for Health Metrics and Evaluationの報告書によると、世界の首の痛みの症例は2050年までに2億6,900万人（範囲は2億1900万人から3億2,200万人）に達すると予測されており、これは2020年と比較して32.5％（23.9％から42.3％）の増加を反映しています。このように、慢性疼痛患者の増加が慢性疼痛市場の成長を牽引しています。

社会における高齢者の割合の増加を特徴とする人口動態の高齢化は、慢性疼痛市場の拡大に大きく寄与しています。人口の高齢化に伴い、慢性疼痛管理戦略への依存度が高まり、加齢に関連した状態に対処し、全体的な心身の健康を促進します。2022年10月の世界保健機関（WHO）の予測によると、60歳以上の世界人口は2050年までに倍増し、21億人に達します。この動向は、高齢化社会のニーズに対応するための慢性疼痛管理ソリューションに対する需要が引き続き急増することを示唆しており、それによって市場の成長が促進されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の慢性疼痛PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の慢性疼痛市場：成長率分析
• 世界の慢性疼痛市場の実績：規模と成長, 2019-2024
• 世界の慢性疼痛市場の予測：規模と成長, 2024-2029, 2034F
• 世界の慢性疼痛総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の慢性疼痛市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤
• デバイス
• 世界の慢性疼痛市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経障害性疼痛
• 関節炎の痛み
• 慢性腰痛
• がんの痛み
• 片頭痛
• 線維筋痛症
• その他の適応症
• 世界の慢性疼痛市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 研究機関
• 世界の慢性疼痛市場、タイプ別サブセグメンテーション：薬剤、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非オピオイド鎮痛剤
• オピオイド
• 抗うつ薬
• 抗けいれん薬
• 局所鎮痛剤
• コルチコステロイド
• 世界の慢性疼痛市場、タイプ別サブセグメンテーション：デバイス、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮的電気神経刺激装置（TENS）
• 脊髄刺激装置
• 脊髄内ドラッグデリバリーシステム
• 温熱・寒冷療法機器
• バイオエレクトロニクスデバイス

第7章 地域別・国別分析

• 世界の慢性疼痛市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の慢性疼痛市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性疼痛市場：競合情勢
• 慢性疼痛市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• Abbott Laboratories
• Mitsubishi Chemical Group Corporation
• GlaxoSmithKline plc.
• Eli Lilly and Company
• AstraZeneca plc.
• Becton, Dickinson, and Company
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Endo International plc.
• Noven Pharmaceuticals Inc.
• Anika Therapeutics Inc.
• Collegium Pharmaceutical Inc.
• Heron Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 慢性疼痛市場2029：新たな機会を提供する国
• 慢性疼痛市場2029：新たな機会を提供するセグメント
• 慢性疼痛市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Chronic pain is characterized by persistent or long-lasting discomfort that extends beyond the normal healing period following an injury or illness. It can have diverse origins, including injuries, underlying medical conditions, nerve damage, inflammation, musculoskeletal disorders, and specific diseases such as arthritis, fibromyalgia, or neuropathy.

The primary products utilized for managing chronic pain are drugs and devices. Drugs refer to substances used for diagnosing, preventing, or treating diseases or medical conditions. Commonly employed medications for chronic pain include opioids and non-steroidal anti-inflammatory drugs (NSAIDs), aimed at alleviating pain symptoms and addressing underlying causes. These drugs are utilized for various indications, including neuropathic pain, arthritis pain, chronic back pain, cancer pain, migraines, fibromyalgia, and others. End-users of these products include hospitals, clinics, and research organizations.

The chronic pain market research report is one of a series of new reports from The Business Research Company that provides chronic pain market statistics, including chronic pain industry global market size, regional shares, competitors with a chronic pain market share, detailed chronic pain market segments, market trends and opportunities, and any further data you may need to thrive in the chronic pain industry. This chronic pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic pain market size has grown strongly in recent years. It will grow from $78.79 billion in 2024 to $84.96 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to injury and trauma, surgical procedures, inflammatory conditions, nerve damage and neuropathy, lack of effective treatments

The chronic pain market size is expected to see strong growth in the next few years. It will grow to $117.74 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to aging population, telemedicine expansion, public health awareness, genetic research and precision medicine, psychosocial stressors. Major trends in the forecast period include integration of wearable devices, pain education and support groups, holistic pain management, non-opioid pain management, regenerative medicine for pain.

The increasing prevalence of chronic pain patients is anticipated to boost the growth of the chronic pain market. Chronic pain patients are those who experience ongoing or long-lasting pain that extends beyond the typical healing process, generally lasting over three months. The high number of chronic pain patients propels market growth, as the rising demand for effective pain management solutions, including pharmaceuticals and medical devices, creates opportunities for innovation and development within the industry. For instance, in June 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that an estimated 4.0 million Australians (16% of the population) were living with back problems in 2022. By 2023, back issues had become the third leading cause of disease burden, accounting for 4.3% of the country's total disease burden. Additionally, in February 2024, a report from the Institute for Health Metrics and Evaluation, a US-based public health agency and research institute, projected that global cases of neck pain are expected to reach 269 million by 2050 (with a range of 219 to 322 million), reflecting a 32.5% increase (between 23.9% and 42.3%) compared to 2020. Thus, the prevalence of chronic pain patients is driving the growth of the chronic pain market.

The aging demographic, characterized by a larger proportion of elderly individuals in society, contributes significantly to the expansion of the chronic pain market. As the population ages, there's an augmented reliance on chronic pain management strategies to address age-related conditions, promoting overall physical and mental well-being. According to the World Health Organization's projections from October 2022, the global population aged 60 years and older is set to double by 2050, reaching 2.1 billion. This trend suggests a continued upsurge in demand for chronic pain management solutions to cater to the needs of the aging population, thereby driving market growth.

Companies in the chronic pain market are actively concentrating on novel and user-friendly nerve stimulation devices employing electrical impulses to alleviate pain. These portable devices provide non-invasive pain management options. For instance, Abbott Laboratories, a prominent US healthcare firm, introduced Eterna in December 2022. Eterna stands as the most compact implantable and rechargeable spinal cord stimulation (SCS) system available. Utilizing Abbott's unique low-dose BurstDR stimulation, it demonstrated a 23% greater pain reduction compared to traditional waveform technologies, supported by extensive clinical evidence (1A evidence).

Major players in the chronic pain market are embracing a strategic partnership approach to introduce a shared savings program aimed at managing chronic pain effectively. This collaborative strategy involves leveraging the combined strengths and resources of involved companies. In August 2023, MOBE, a US-based digital health innovator, joined forces with Override Health, a healthcare company in the US. Their shared objective is to address chronic pain management through a program that amalgamates their respective expertise. MOBE employs healthcare data analytics for high-touch, one-to-one health coaching and medication management, while Override Health offers virtual interdisciplinary care, neuroplasticity-centered coaching, and peer support to assist individuals navigating the complexities of chronic pain.

In October 2024, Stryker Corporation, a medical technology company based in the US, acquired Vertos Medical Inc. for an undisclosed sum. This acquisition aims to enhance unique, non-surgical solutions for interventionalists treating chronic lower back pain and to expand their presence in ambulatory surgery centers. Vertos Medical Inc. is a US-based manufacturer specializing in devices for chronic pain management, with a specific focus on treatments for chronic lower back pain resulting from lumbar spinal stenosis.

Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic pain market consists of sales of opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, and other analgesics that are used to manage chronic pain. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Pain Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic pain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Drug; Devices
• 2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications
• 3) By End User: Hospitals; Clinics; Research Organization
• Subsegments:
• 1) By Drug: Non-Opioid Analgesics; Opioids; Antidepressants; Anticonvulsants; Topical Analgesics; Corticosteroids
• 2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units; Spinal Cord Stimulators; Intrathecal Drug Delivery Systems; Heat And Cold Therapy Devices; Bioelectronic Devices
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Novartis AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Pain Market Characteristics

3. Chronic Pain Market Trends And Strategies

4. Chronic Pain Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Chronic Pain Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Pain PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Pain Market Growth Rate Analysis
• 5.4. Global Chronic Pain Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Pain Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Pain Total Addressable Market (TAM)

6. Chronic Pain Market Segmentation

• 6.1. Global Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug
• Devices
• 6.2. Global Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuropathic Pain
• Arthritis Pain
• Chronic Back Pain
• Cancer Pain
• Migraine
• Fibromyalgia
• Other Indications
• 6.3. Global Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Organization
• 6.4. Global Chronic Pain Market, Sub-Segmentation Of Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Opioid Analgesics
• Opioids
• Antidepressants
• Anticonvulsants
• Topical Analgesics
• Corticosteroids
• 6.5. Global Chronic Pain Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcutaneous Electrical Nerve Stimulation (TENS) Units
• Spinal Cord Stimulators
• Intrathecal Drug Delivery Systems
• Heat And Cold Therapy Devices
• Bioelectronic Devices

7. Chronic Pain Market Regional And Country Analysis

• 7.1. Global Chronic Pain Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Pain Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Pain Market

• 8.1. Asia-Pacific Chronic Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Pain Market

• 9.1. China Chronic Pain Market Overview
• 9.2. China Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Pain Market

• 10.1. India Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Pain Market

• 11.1. Japan Chronic Pain Market Overview
• 11.2. Japan Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Pain Market

• 12.1. Australia Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Pain Market

• 13.1. Indonesia Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Pain Market

• 14.1. South Korea Chronic Pain Market Overview
• 14.2. South Korea Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Pain Market

• 15.1. Western Europe Chronic Pain Market Overview
• 15.2. Western Europe Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Pain Market

• 16.1. UK Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Pain Market

• 17.1. Germany Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Pain Market

• 18.1. France Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Pain Market

• 19.1. Italy Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Pain Market

• 20.1. Spain Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Pain Market

• 21.1. Eastern Europe Chronic Pain Market Overview
• 21.2. Eastern Europe Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Pain Market

• 22.1. Russia Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Pain Market

• 23.1. North America Chronic Pain Market Overview
• 23.2. North America Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Pain Market

• 24.1. USA Chronic Pain Market Overview
• 24.2. USA Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Pain Market

• 25.1. Canada Chronic Pain Market Overview
• 25.2. Canada Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Pain Market

• 26.1. South America Chronic Pain Market Overview
• 26.2. South America Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Pain Market

• 27.1. Brazil Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Pain Market

• 28.1. Middle East Chronic Pain Market Overview
• 28.2. Middle East Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Pain Market

• 29.1. Africa Chronic Pain Market Overview
• 29.2. Africa Chronic Pain Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Pain Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Pain Market Competitive Landscape And Company Profiles

• 30.1. Chronic Pain Market Competitive Landscape
• 30.2. Chronic Pain Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Pain Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. Abbott Laboratories
• 31.3. Mitsubishi Chemical Group Corporation
• 31.4. GlaxoSmithKline plc.
• 31.5. Eli Lilly and Company
• 31.6. AstraZeneca plc.
• 31.7. Becton, Dickinson, and Company
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Regeneron Pharmaceuticals Inc.
• 31.10. Biogen Inc.
• 31.11. Endo International plc.
• 31.12. Noven Pharmaceuticals Inc.
• 31.13. Anika Therapeutics Inc.
• 31.14. Collegium Pharmaceutical Inc.
• 31.15. Heron Therapeutics Inc.

32. Global Chronic Pain Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Pain Market

34. Recent Developments In The Chronic Pain Market

35. Chronic Pain Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Pain Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Pain Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Pain Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer